Biomaterial Database

Visceral leishmaniasis in HIV-infected patients. 1990

P J Flegg, and R P Brettle

UI	MeSH Term	Description	Entries
D007898	Leishmaniasis, Visceral	A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.	Black Fever,Kala-Azar,Fever, Black,Kala Azar,Visceral Leishmaniasis
D007958	Leukocyte Count	The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells.	Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D002487	Centers for Disease Control and Prevention, U.S.	An agency of the UNITED STATES PUBLIC HEALTH SERVICE that conducts and supports programs for the prevention and control of disease and provides consultation and assistance to health departments and other countries.	United States Centers for Disease Control and Prevention,CDC,CDCP,Center for Disease Control,Center for Disease Control and Prevention,Centers for Disease Control,Centers for Disease Control (U.S.),Centers for Disease Control and Prevention,Centers for Disease Control and Prevention (U.S.),Centers for Disease Control, U.S.,United States Centers for Disease Control
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000981	Antiprotozoal Agents	Substances that are destructive to protozoans.	Schizonticides,Agents, Antiprotozoal
D014481	United States	A country in NORTH AMERICA between CANADA and MEXICO.
D015496	CD4-Positive T-Lymphocytes	A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes.	T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015658	HIV Infections	Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS).	HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

P J Flegg, and R P Brettle

Visceral leishmaniasis in HIV-infected patients.

October 1991, AIDS (London, England),

P J Flegg, and R P Brettle

Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.

July 2011, Ethiopian medical journal,

P J Flegg, and R P Brettle

Diagnosis of visceral leishmaniasis in HIV-infected patients.

December 1996, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,

P J Flegg, and R P Brettle

Visceral leishmaniasis--an opportunistic infection in HIV-infected patients.

April 2005, The Lancet. Infectious diseases,

P J Flegg, and R P Brettle

Visceral Leishmaniasis in Hospitalized HIV-Infected Patients in Pernambuco, Brazil.

December 2018, The American journal of tropical medicine and hygiene,

P J Flegg, and R P Brettle

Visceral leishmaniasis in patients infected with human immunodeficiency virus (HIV).

July 1989, Annals of internal medicine,

P J Flegg, and R P Brettle

Visceral leishmaniasis in HIV-infected patients in the south of France.

January 1995, Bulletin of the World Health Organization,